Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8.
about
Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathophysiology and management.Heparin-induced thrombocytopenia: pathogenesis and management.PF4/heparin complexes are T cell-dependent antigens.Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.Heparin-induced thrombocytopenia: treatment options and special considerations.Heparin induced thrombocytopenia with thrombosis: a two step process?Pathobiology of secondary immune thrombocytopenia.Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementEffect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).Heparin-induced thrombocytopenia: overview and treatment.PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model.Heparin-induced thrombocytopenia: present and future.An overview of heparin-induced thrombocytopenia.The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia in the pediatric population: a review of current literatureAcute stent thrombosis and heparin induced thrombocytopenia: another manifestation of kounis syndrome?Heparin induced thrombocytopenia: review.Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophagesPlatelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.An update on heparin-induced thrombocytopenia: diagnosis and management.Drug-induced thrombosis--experimental, clinical, and mechanistic considerations.Drug-induced thrombosis: an update.Kounis syndrome: a monster for the atopic patient.5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?
P2860
Q30483035-9D0016F1-6E25-4CF4-8EDF-2B54CAA92715Q30497774-C4C7DEAA-CCDC-4B48-86CC-6D837BDFDEC3Q33342924-B31C3506-5C66-4AB8-B5BE-94CF6F8D325AQ33348049-3BF32A19-A0A7-4EB4-88B3-4B6289157785Q33365918-590F35B2-7B20-433A-A6F0-8C248086DBD0Q33369316-E5D9B520-3E53-4ECA-AECA-5A617616C38BQ33374658-149605F4-C9C5-483A-8A91-E079281507BDQ33380753-E14F3420-758D-4DFF-A38D-27616791D376Q33383468-F696684C-6149-445D-AA41-562ED4F44C08Q33384003-DF223B5A-DF7A-4537-83DE-8B3F7736DC38Q33385134-C99D131D-173A-4762-A19A-A4C6A6945846Q33385510-BDF72CE4-0375-4E09-9BA4-1C0387F64B36Q33386197-94D8B314-CA3B-4FA3-9595-8FDD7B895754Q33392880-F4B46423-B65D-4904-99F3-6FB9972A9B64Q33394188-BE057311-E353-43C8-B783-1F9DDF86E604Q33394986-7FCE64CC-1765-4718-BD79-DA956E316F23Q33396756-A5195A5B-C63B-4186-A4B9-D0CF59B8E915Q33400120-629B9698-8BE6-423A-9576-E2993D034811Q33402501-C326433D-7259-415F-86FD-34481785565FQ33404178-68222472-2B27-4DC6-B876-14DEE626DF9EQ33407799-A1B55DD5-D772-452B-86FD-3DC90CF4829FQ33410083-491CBEC7-3B85-4687-95A7-0B15CAB19FACQ33410242-4C3DB770-DB3D-496C-8259-619901A5D55FQ33416269-21B92245-9E1F-41DD-BF6B-C9C5BAC58BF3Q33422720-38BA423C-9459-4D62-AA0E-72A3726AD23AQ33427182-95150EA8-9D17-4F2D-9E81-A13D2FDF84F9Q33430644-543924AB-1A18-447E-A254-146FC3529223Q36762200-50A374BD-F669-43CB-A9FB-E5E8636FA965Q38103820-5A4CC90B-C105-4A98-B42C-B9AFE98B3821Q41809153-2BAF723D-955F-4FA8-94B7-0D67D1A69742Q52552212-5ED96A42-F61D-4B0A-A9D5-852DDE45C7B7Q53085054-DBA29040-55C8-442A-BE23-02F8623C1E9E
P2860
Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antibodies from patients with ...... tor and secrete interleukin-8.
@ast
Antibodies from patients with ...... tor and secrete interleukin-8.
@en
Antibodies from patients with ...... tor and secrete interleukin-8.
@nl
type
label
Antibodies from patients with ...... tor and secrete interleukin-8.
@ast
Antibodies from patients with ...... tor and secrete interleukin-8.
@en
Antibodies from patients with ...... tor and secrete interleukin-8.
@nl
prefLabel
Antibodies from patients with ...... tor and secrete interleukin-8.
@ast
Antibodies from patients with ...... tor and secrete interleukin-8.
@en
Antibodies from patients with ...... tor and secrete interleukin-8.
@nl
P921
P356
P1433
P1476
Antibodies from patients with ...... tor and secrete interleukin-8.
@en
P2093
P304
P356
10.1182/BLOOD.V98.4.1252
P407
P577
2001-08-01T00:00:00Z